Omaxe Chairman Rohtas Goel

Omaxe will consider challenging market regulator SEBI's order that barred the firm, its Chairman Rohtas Goel, MD Mohit Goel and three others from the securities market for two years for misrepresentation in the company's financial statements.

Sebi on Tuesday barred real estate firm Omaxe, its chairman Rohtas Goel, managing director Mohit Goel and three others from the securities market for two years for irregularities in the company's financial statements.

Real estate firm Omaxe Ltd sold residential and commercial properties worth Rs 1,648 crore in last fiscal, up 11 per cent from the 2014-15, despite fall in average sales realisation.

Omaxe will consider challenging market regulator SEBI's order that barred the firm, its Chairman Rohtas Goel, MD Mohit Goel and three others from the securities market for two years for misrepresentation in the company's financial statements.

Sebi on Tuesday barred real estate firm Omaxe, its chairman Rohtas Goel, managing director Mohit Goel and three others from the securities market for two years for irregularities in the company's financial statements.

Real estate firm Omaxe Ltd sold residential and commercial properties worth Rs 1,648 crore in last fiscal, up 11 per cent from the 2014-15, despite fall in average sales realisation.